HIV prevention for injecting drug users: The first 25 years and counting

Don Des Jarlais, Salaam Semaan

Research output: Contribution to journalReview article

Abstract

Effective treatment regimens for HIV infection demand very high levels of adherence and people infected with HIV are expected to adhere to safer sex and drug use practices throughout their lives. Treatment nonadherence overlaps with continued unsafe sexual practices for some people living with HIV/AIDS. The co-occurrence of nonadherence and HIV transmission risk behavior poses particular risk for the spread of drug-resistant variants of HIV. There are common correlates of both nonadherence and risk behavior, particularly substance use and depression. Interventions designed to address treatment nonadherence and those designed to reduce risk behavior also share common elements, particularly self-efficacy enhancement and behavioral skills training. The common correlates and shared intervention elements suggest that integrated intervention approaches that simultaneously address adherence and risk reduction may be feasible. Research is currently testing interventions that simultaneously increase HIV treatment adherence and reduce behaviors that risk HIV transmission.

Original languageEnglish (US)
Pages (from-to)606-611
Number of pages6
JournalPsychosomatic Medicine
Volume70
Issue number5
DOIs
StatePublished - Jan 1 2008

Fingerprint

Drug Users
HIV
Risk-Taking
Safe Sex
Self Efficacy
Risk Reduction Behavior
Therapeutics
Pharmaceutical Preparations
HIV Infections
Acquired Immunodeficiency Syndrome
Depression
Research

Keywords

  • HIV/AIDS prevention
  • HIV/AIDS treatment
  • Interventions

ASJC Scopus subject areas

  • Applied Psychology
  • Psychiatry and Mental health

Cite this

HIV prevention for injecting drug users : The first 25 years and counting. / Des Jarlais, Don; Semaan, Salaam.

In: Psychosomatic Medicine, Vol. 70, No. 5, 01.01.2008, p. 606-611.

Research output: Contribution to journalReview article

@article{e068a263e9c64259be82f2e672423071,
title = "HIV prevention for injecting drug users: The first 25 years and counting",
abstract = "Effective treatment regimens for HIV infection demand very high levels of adherence and people infected with HIV are expected to adhere to safer sex and drug use practices throughout their lives. Treatment nonadherence overlaps with continued unsafe sexual practices for some people living with HIV/AIDS. The co-occurrence of nonadherence and HIV transmission risk behavior poses particular risk for the spread of drug-resistant variants of HIV. There are common correlates of both nonadherence and risk behavior, particularly substance use and depression. Interventions designed to address treatment nonadherence and those designed to reduce risk behavior also share common elements, particularly self-efficacy enhancement and behavioral skills training. The common correlates and shared intervention elements suggest that integrated intervention approaches that simultaneously address adherence and risk reduction may be feasible. Research is currently testing interventions that simultaneously increase HIV treatment adherence and reduce behaviors that risk HIV transmission.",
keywords = "HIV/AIDS prevention, HIV/AIDS treatment, Interventions",
author = "{Des Jarlais}, Don and Salaam Semaan",
year = "2008",
month = "1",
day = "1",
doi = "10.1097/PSY.0b013e3181772157",
language = "English (US)",
volume = "70",
pages = "606--611",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - HIV prevention for injecting drug users

T2 - The first 25 years and counting

AU - Des Jarlais, Don

AU - Semaan, Salaam

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Effective treatment regimens for HIV infection demand very high levels of adherence and people infected with HIV are expected to adhere to safer sex and drug use practices throughout their lives. Treatment nonadherence overlaps with continued unsafe sexual practices for some people living with HIV/AIDS. The co-occurrence of nonadherence and HIV transmission risk behavior poses particular risk for the spread of drug-resistant variants of HIV. There are common correlates of both nonadherence and risk behavior, particularly substance use and depression. Interventions designed to address treatment nonadherence and those designed to reduce risk behavior also share common elements, particularly self-efficacy enhancement and behavioral skills training. The common correlates and shared intervention elements suggest that integrated intervention approaches that simultaneously address adherence and risk reduction may be feasible. Research is currently testing interventions that simultaneously increase HIV treatment adherence and reduce behaviors that risk HIV transmission.

AB - Effective treatment regimens for HIV infection demand very high levels of adherence and people infected with HIV are expected to adhere to safer sex and drug use practices throughout their lives. Treatment nonadherence overlaps with continued unsafe sexual practices for some people living with HIV/AIDS. The co-occurrence of nonadherence and HIV transmission risk behavior poses particular risk for the spread of drug-resistant variants of HIV. There are common correlates of both nonadherence and risk behavior, particularly substance use and depression. Interventions designed to address treatment nonadherence and those designed to reduce risk behavior also share common elements, particularly self-efficacy enhancement and behavioral skills training. The common correlates and shared intervention elements suggest that integrated intervention approaches that simultaneously address adherence and risk reduction may be feasible. Research is currently testing interventions that simultaneously increase HIV treatment adherence and reduce behaviors that risk HIV transmission.

KW - HIV/AIDS prevention

KW - HIV/AIDS treatment

KW - Interventions

UR - http://www.scopus.com/inward/record.url?scp=50949104357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949104357&partnerID=8YFLogxK

U2 - 10.1097/PSY.0b013e3181772157

DO - 10.1097/PSY.0b013e3181772157

M3 - Review article

C2 - 18519886

AN - SCOPUS:50949104357

VL - 70

SP - 606

EP - 611

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 5

ER -